Axelle Emmanuelle Landis, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6333 E Menser Ave, Athol, ID 83801 Phone: 208-683-2231 |
Sarah Desimone, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6101 E Highway 54 Ste A, Athol, ID 83801 Phone: 208-994-3757 Fax: 208-352-3921 |
Lynne Kaulback Orange, M.ED., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11111 E Arroyo Ln, Athol, ID 83801 Phone: 650-556-4225 |
Huckleberry Therapy Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6101 E Highway 54, Ste A, Athol, ID 83801 Phone: 208-994-3757 Fax: 208-352-3921 |
News Archive
Burkitt lymphoma is a malignant, fast-growing tumor that originates from a subtype of white blood cells called B lymphocytes of the immune system and often affects internal organs and the central nervous system. Now Dr. Sandrine Sander and Professor Klaus Rajewsky of the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch have identified a key element that transforms the immune cells into malignant lymphoma cells.
Echo Therapeutics, Inc., a company developing its needle-free Symphony CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced financial results for the quarter ended March 31, 2013.
The doctor-led Coalition to Protect Patients' Rights (Coalition) urged caution to legislators and the public as they consider Senate Finance Chairman Max Baucus's healthcare reform proposal, America's Healthy Future Act of 2009, which was released today.
An audit of U.S. projects to rebuild Afghanistan found a 'confusing labyrinth' of agencies and contractors in a poorly coordinated aid effort that cannot easily demonstrate how money is being spent, a report from the Special Inspector General for Afghanistan Reconstruction (SIGAR) said on Wednesday, Reuters reports.
BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today announced the first sale of the IOPtiMateā¢ system to a medical center located in Hungary.
› Verified 4 days ago